RETA Reata Pharmaceuticals Inc

在31/12/2022結束的金融年度: Reata Pharmaceuticals Inc的營收decreased by 80.71% ，達到 2.22M。淨利decreased by 4.88%至-311.90M。淨資產decreased by 135.32%到-65.70M；每股盈餘從-8.19decreased到-8.54。